NTMT1
MOLECULAR TARGETN-terminal Xaa-Pro-Lys N-methyltransferase 1
NTMT1 (N-terminal Xaa-Pro-Lys N-methyltransferase 1) is targeted by 75 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NTMT1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 75 compounds. Use the BiohacksAI search to explore all NTMT1 modulators.
About NTMT1 as a Drug Target
NTMT1 (N-terminal Xaa-Pro-Lys N-methyltransferase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 75 compounds with documented NTMT1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NTMT1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.